Hospital.Help

Oxford – The switch from the live shingles vaccine Zostavax to the recombinant vaccine Shingrix, which took place in the USA in October 2017, has led to a decline in dementia among those vaccinated. This is shown by an analysis of electronic medical records in Nature Medicine (2024; DOI: 10.1038/s41591-024-03201-5). Several research groups have observed in recent years that seniors after a…